ArticleDiagnostics (Basel, Switzerland)2021

Predictive and Prognostic Impact of Blood-Based Inflammatory Biomarkers in Patients with Gastroenteropancreatic Neuroendocrine Tumors Commencing Peptide Receptor Radionuclide Therapy.

Fiona Ohlendorf et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.